Q2869391 (Q2869391): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Created claim: summary (P836): REDESEVMED with this intervention will increase the existing production capacity (laboratorial) for the massification of (industrial) production of biomedical products, in particular individualised grafts for bone regeneration., translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
REDESEVMED with this intervention will increase the existing production capacity (laboratorial) for the massification of (industrial) production of biomedical products, in particular individualised grafts for bone regeneration. (English) | |||||||||||||||
Property / summary: REDESEVMED with this intervention will increase the existing production capacity (laboratorial) for the massification of (industrial) production of biomedical products, in particular individualised grafts for bone regeneration. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: REDESEVMED with this intervention will increase the existing production capacity (laboratorial) for the massification of (industrial) production of biomedical products, in particular individualised grafts for bone regeneration. (English) / qualifier | |||||||||||||||
point in time: 7 July 2021
|
Revision as of 02:00, 7 July 2021
Project Q2869391 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q2869391 in Portugal |
Statements
201,600.0 Euro
0 references
79.0 percent
0 references
16 September 2016
0 references
15 September 2017
0 references
RESDEVMED, LDA
0 references
A REDESEVMED com esta intervenção irá aumentar a capacidade produtiva existente (laboratorial), para a massificação da produção (industrial), de produtos biomédicos, em especial enxertos individualizados para regeneração óssea. (Portuguese)
0 references
REDESEVMED with this intervention will increase the existing production capacity (laboratorial) for the massification of (industrial) production of biomedical products, in particular individualised grafts for bone regeneration. (English)
7 July 2021
0 references
Ovar
0 references
Identifiers
CENTRO-02-0853-FEDER-022620
0 references